Neurocode USA Inc, a leading clinical laboratory specializing in blood biomarkers for Alzheimer’s disease (AD) diagnosis, is pleased to announce the publication of a groundbreaking new study comparing the performance of two prominent pTau217 assays: the ALZpath assay and the Fujirebio assay.
Your privacy is our priority
- Hosted on Secure cloud-based hosting
- SOC II Type 1
- HIPAA compliant
- 2FA authentication
- End-to-end data encryption
- Your health data will not be sold or used without your consent. Ever.
